BRCA2 loss in Fanconi Anemia

被引：0
|
作者：
Weitzman J.B.
机构：
来源：
Genome Biology | / 3卷 / 1期
关键词：
Breast Cancer; Anemia; Cancer Susceptibility; Fanconi Anemia; Breast Cancer Susceptibility;
D O I：
10.1186/gb-spotlight-20020614-01
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [31] BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2
    Bernard-Gallon, D
    De Latour, MP
    Rio, P
    Favy, D
    Hizel, C
    Vissac, C
    Bignon, YJ
    INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (04) : 453 - 456
  • [32] Immunohistochemical expression of BRCA2 protein and allelic loss at the BRCA2 locus in prostate cancer
    Edwards, SM
    Dunsmuir, WD
    Gillett, CE
    Lakhani, SR
    Corbishley, C
    Young, M
    Kirby, RS
    Dearnaley, DP
    Dowe, A
    Ardern-Jones, A
    Kelly, J
    Spurr, N
    Barnes, DM
    Eeles, RA
    INTERNATIONAL JOURNAL OF CANCER, 1998, 78 (01) : 1 - 7
  • [33] Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report
    Loizidou, Maria A.
    Hadjisavvas, Andreas
    Tanteles, George A.
    Spanou-Aristidou, Elena
    Kyriacou, Kyriacos
    Christophidou-Anastasiadou, Violetta
    ONCOLOGY LETTERS, 2016, 11 (01) : 471 - 473
  • [34] A Novel Splice Site Mutation in the Noncoding Region of BRCA2: Implications for Fanconi Anemia and Familial Breast Cancer Diagnostics
    Bakker, Janine L.
    Thirthagiri, Eswary
    van Mil, Saskia E.
    Adank, Muriel A.
    Ikeda, Hideyuki
    Verheul, Henk M. W.
    Meijers-Heijboer, Hanne
    de Winter, Johan P.
    Sharan, Shyam K.
    Waisfisz, Quinten
    HUMAN MUTATION, 2014, 35 (04) : 442 - 446
  • [35] Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia and Fanconi anemia.
    Auerbach, AD
    Tolar, J
    Levran, O
    Satagopan, J
    Ben-Porat, L
    Mah, K
    Kutler, DI
    Batish, SD
    MacMillan, ML
    Hanenberg, H
    Wagner, JE
    BLOOD, 2003, 102 (11) : 23A - 23A
  • [36] EARLY POST-NATAL WILMS TUMOR AND CYTOGENETIC ANALYSIS LED TO THE DIAGNOSIS OF FANCONI ANEMIA WITH BRCA2 MUTATION
    Nakazawa, Yo
    Tasaka, Keiji
    Kato, Itaru
    Akazawa, Ryo
    Ogawa, Eri
    Saida, Satoshi
    Umeda, Katsutsugu
    Hiramatsu, Hidefumi
    Arakawa, Yoshiki
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S65 - S66
  • [37] Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2
    Ikeda, H
    Matsushita, M
    Waisfisz, Q
    Kinoshita, A
    Oostra, AB
    Nieuwint, AWM
    de Winter, JP
    Hoatlin, ME
    Kawai, Y
    Sasaki, MS
    D'Andrea, AD
    Kawakami, Y
    Joenje, H
    CANCER RESEARCH, 2003, 63 (10) : 2688 - 2694
  • [38] Squamous Cell Lung Cancer Risk Is Associated with Rare, Pathogenic Germline Variants in BRCA2 and Fanconi Anemia Genes
    Selvan, M. Esai
    Klein, R.
    Gumus, Z.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S522 - S522
  • [39] Fanconi anemia with biallelic FANCD1/BRCA2 mutations - Case report of a family with three affected children
    Svojgr, Karel
    Sumerauer, David
    Puchmajerova, Alena
    Vicha, Ales
    Hrusak, Ondrej
    Michalova, Kyra
    Malis, Josef
    Smisek, Petr
    Kyncl, Martin
    Novotna, Drahuse
    Machackova, Eva
    Jencik, Jan
    Pycha, Karel
    Vaculik, Miroslav
    Kodet, Roman
    Stary, Jan
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2016, 59 (03) : 152 - 157
  • [40] A practice changing paper: biallelic inactivation of BRCA2 in Fanconi anaemia
    Diana Prepelita
    Marc Tischkowitz
    BJC Reports, 2 (1):
12345